Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 900.71B, Eli Lilly(LLY) trades at $955.00. The stock has a price-to-earnings ratio of 41.54 and currently yields dividends of 65.4%.
During the trading session on 2026-04-09, Eli Lilly(LLY) shares reached a daily high of $957.25 and a low of $951.59. At a current price of $955.00, the stock is +0.4% higher than the low and still -0.2% under the high.
Trading volume for Eli Lilly(LLY) stock has reached 16.04K, versus its average volume of 2.97M.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.
LLY News
Amazon Pharmacy (AMZN) now offers Eli Lilly and Company’s (LLY) recently approved GLP-1 medication, Foundayo, a once daily oral treatment for adults with obesit...
GoodRx (GDRX) announced that it is working with Eli Lilly and Company (LLY) to expand access to the newly FDA-approved oral GLP-1 medication, Foundayo. Eligible...
Eli Lilly’s Foundayo weight-loss pill is now available in the U.S. following the Food and Drug Administration’s approval earlier this month. Mike Blake/Reuters...
Analyst ratings
83%
of 35 ratingsMore LLY News
Mounjaro Losing Its Exclusivity Mounjaro, which was previously a top-selling drug, is now facing headwinds as competitors enter the market, according to a repor...
Eli Lilly (NYSE:LLY) agreed to acquire Centessa Pharmaceuticals for $7.8b, adding late stage sleep disorder therapies to its pipeline. The company secured $2.2...
Key Points These two companies operate in a high-growth market, one that’s heading toward $100 billion, according to analysts’ forecasts. Their products have...
Some are starting to worry that Lilly, which for a short time vaulted into the trillion-dollar market cap club, may have hit a plateau. Eli Lilly, the most val...
Novo Nordisk has launched the high-dose version of its GLP-1 injection at a price that’s $50 lower than the one for Eli Lilly’s competing drug. For patients pa...
Healthcare The $190 Billion ‘Diabesity’ Market Is Set to Explode. Lilly and Novo Face These Stock Catalysts. In this article LLY NVO HIMS NOVO.B AMGN Eli Lilly’...
Eli Lilly (LLY) CEO Dave Ricks says the pharmaceutical company is ready to scale production of its newly approved weight-loss pill, Foundayo, to meet global dem...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.